» Articles » PMID: 21454669

Wnt5a-dopamine D2 Receptor Interactions Regulate Dopamine Neuron Development Via Extracellular Signal-regulated Kinase (ERK) Activation

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2011 Apr 2
PMID 21454669
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The dopamine D2 receptor (D2R) plays an important role in mesencephalic dopaminergic neuronal development, particularly coupled with extracellular signal-regulated kinase (ERK) activation. Wnt5a protein is known to regulate the development of dopaminergic neurons. We analyzed the effect of Wnt5a on dopaminergic neuron development in mesencephalic primary cultures from wild-type (WT) and D2R knock-out (D2R(-/-)) mice. Treatment with Wnt5a increased the number and neuritic length of dopamine neurons in primary mesencephalic neuronal cultures from WT mice, but not from D2R(-/-) mice. The effect of Wnt5a was completely blocked by treatment with D2R antagonist or inhibitors of MAPK or EGFR. Wnt5a-mediated ERK activation in mesencephalic neuronal cultures was inhibited by treatment of D2R antagonist and EGFR inhibitors in WT mice. However, these regulations were not observed for D2R(-/-) mice. Co-immunoprecipitation and displacement of [(3)H]spiperone from D2R by Wnt5a demonstrated that Wnt5a could bind with D2R. This interaction was confirmed by GST pulldown assays demonstrating that the domain including transmembrane domain 4, second extracellular loop, and transmembrane domain 5 of D2R binds to Wnt5a. These results suggest that the interaction between D2R and Wnt5a has an important role in dopamine neuron development in association with EGFR and the ERK pathway.

Citing Articles

Long-Term Hypoxia Maintains a State of Dedifferentiation and Enhanced Stemness in Fetal Cardiovascular Progenitor Cells.

Knox C, Camberos V, Ceja L, Monteon A, Hughes L, Longo L Int J Mol Sci. 2021; 22(17).

PMID: 34502291 PMC: 8431563. DOI: 10.3390/ijms22179382.


E2F1-mediated repression of WNT5A expression promotes brain metastasis dependent on the ERK1/2 pathway in EGFR-mutant non-small cell lung cancer.

Li H, Tong F, Meng R, Peng L, Wang J, Zhang R Cell Mol Life Sci. 2020; 78(6):2877-2891.

PMID: 33078208 PMC: 11072416. DOI: 10.1007/s00018-020-03678-6.


Dopamine D3 Receptor Heteromerization: Implications for Neuroplasticity and Neuroprotection.

Bono F, Mutti V, Fiorentini C, Missale C Biomolecules. 2020; 10(7).

PMID: 32659920 PMC: 7407647. DOI: 10.3390/biom10071016.


Selective Effects of Thioridazine on Self-Renewal of Basal-Like Breast Cancer Cells.

Tegowski M, Fan C, Baldwin A Sci Rep. 2019; 9(1):18695.

PMID: 31822725 PMC: 6904738. DOI: 10.1038/s41598-019-55145-3.


Cancer and the Dopamine D Receptor: A Pharmacological Perspective.

Weissenrieder J, Neighbors J, Mailman R, Hohl R J Pharmacol Exp Ther. 2019; 370(1):111-126.

PMID: 31000578 PMC: 6558950. DOI: 10.1124/jpet.119.256818.


References
1.
An J, Cho S, Jeong D, Park K, Ahn Y, Baik J . Anti-proliferative effects and cell death mediated by two isoforms of dopamine D2 receptors in pituitary tumor cells. Mol Cell Endocrinol. 2003; 206(1-2):49-62. DOI: 10.1016/s0303-7207(03)00236-3. View

2.
Meiergerd S, Patterson T, Schenk J . D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J Neurochem. 1993; 61(2):764-7. DOI: 10.1111/j.1471-4159.1993.tb02185.x. View

3.
Simon H, Bhatt L, Gherbassi D, Sgado P, Alberi L . Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors. Ann N Y Acad Sci. 2003; 991:36-47. View

4.
Lindvall O, Kokaia Z . Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends Pharmacol Sci. 2009; 30(5):260-7. DOI: 10.1016/j.tips.2009.03.001. View

5.
Almeida M, Han L, Bellido T, Manolagas S, Kousteni S . Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem. 2005; 280(50):41342-51. DOI: 10.1074/jbc.M502168200. View